EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacokinetic and pharmacodynamic evaluation of nitrofurantoin against Escherichia coli in a murine urinary tract infection model

Marit Gaastra Maaland, Lotte Jakobsen, Luca Guardabassi, Niels Frimodt-Møller iD

APMIS · 2024

DOI: 10.1111/apm.13409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, 2024. Verfasst von Marit Gaastra Maaland und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark. Hauptthemen laut MEDLINE: Nitrofurantoin, Urinary Tract Infections, Microbial Sensitivity Tests, Escherichia coli Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antimicrobial agent nitrofurantoin is becoming increasingly important for treatment of urinary tract infections (UTIs) due to widespread occurrence of multidrug‐resistant Escherichia coli . Despite many years of use, little data on nitrofurantoin pharmacokinetics (PK) or ‐dynamics (PD) exist. The objective of this study was to (i) evaluate the pharmacokinetics of nitrofurantoin in a mouse model and (ii) use that data to design an in vivo dose fractionation study in an experimental model of UTI with E. coli for determination of the most predictive PK/PD index. Nitrofurantoin concentrations in urine were approximately 100‐fold larger than concentrations in plasma after oral administration of 5, 10, and 20 mg/kg nitrofurantoin. The area under the curve over the minimum inhibitory concentration (AUC/MIC) was weakly correlated to bacterial reduction in urine (r 2 = 0.24), while no such correlation was found for the time that nitrofurantoin stayed above the MIC (T > MIC). Increasing size of single‐dose treatment was significantly correlated to eradication of bacteria in the urine, while this was not apparent when the same doses were divided in 2 or 3 doses 8 or 12 h apart. In conclusion, the results indicate that nitrofurantoin activity against E. coli in urine is driven by AUC/MIC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NitrofurantoinUrinary Tract InfectionsMicrobial Sensitivity TestsEscherichia coli InfectionsEscherichia coliDisease Models, AnimalAnimalsMiceFemaleAnti-Infective Agents, UrinaryAnti-Bacterial AgentsAdministration, Oral

Stichwörter der Autor:innen

Escherichia coliNitrofurantoinmouse infection modelpharmacokinetic/pharmacodynamicurinary tract infection

Substanzen

NitrofurantoinAnti-Infective Agents, UrinaryAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.
  • Microbiology and Infection Control, Statens Serum Institut, Copenhagen S, Denmark.
  • Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen Ø, Denmark.

ORCID-Profile: Niels Frimodt-Møller

Zitieren

APA

Maaland, M. G., Jakobsen, L., Guardabassi, L., & Frimodt-Møller, N. (2024). Pharmacokinetic and pharmacodynamic evaluation of nitrofurantoin against Escherichia coli in a murine urinary tract infection model. APMIS. https://doi.org/10.1111/apm.13409

Vancouver

Maaland MG, Jakobsen L, Guardabassi L, Frimodt-Møller N. Pharmacokinetic and pharmacodynamic evaluation of nitrofurantoin against Escherichia coli in a murine urinary tract infection model. APMIS. 2024. doi:10.1111/apm.13409

BibTeX
@article{Maaland2024,
  author = {Maaland, Marit Gaastra and Jakobsen, Lotte and Guardabassi, Luca and Frimodt-Møller, Niels},
  title = {Pharmacokinetic and pharmacodynamic evaluation of nitrofurantoin against Escherichia coli in a murine urinary tract infection model},
  journal = {APMIS},
  year = {2024},
  doi = {10.1111/apm.13409}
}
Kostenlos starten →